Jamie G. Kates
Known title: Chief Accounting OfficerCIK: 0002029677
Associated companies
Transaction History
| CI | ▲ Buy | Option Exercise | 899 | $137K | 6/12/2026 | View on chart |
| CI | ▼ Sell | Open Market | 899 | $268K | 6/12/2026 | View on chart |
| CI | ▲ Buy | Grant | 205 | $0 | 2/27/2026 | View on chart |
| CI | ▲ Buy | Grant | 609 | $0 | 2/27/2026 | View on chart |
| CI | ▼ Sell | Tax Withholding | 71 | $20K | 2/27/2026 | View on chart |
| CI | ▼ Sell | Tax Withholding | 61 | $18K | 2/27/2026 | View on chart |
| CI | ▲ Buy | Grant | 246 | $0 | 2/28/2025 | View on chart |
| CI | ▼ Sell | Tax Withholding | 51 | $16K | 2/28/2025 | View on chart |
| CI | ▼ Sell | Tax Withholding | 130 | $40K | 2/28/2025 | View on chart |
| CI | ▲ Buy | Grant | 405 | $0 | 2/28/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.